Clostridioides difficile (CD) is a major planetary health burden. A Gram-positive opportunistic pathogen, CD, colonizes the large intestine and is implicated in sepsis, pseudomembranous colitis, and colorectal cancer. C. difficile infection typically following antibiotic exposure results in dysbiosis of the gut microbiome, and is one of the leading causes of diarrhea in the elderly population. While several studies have focused on the toxigenic strains of CD, gut commensals such as Clostridium butyricum (CB) and Clostridium tertium (CT) could harbor toxin/virulence genes, and thus pose a threat to human health. In this study, we sequenced and characterized three isolates, namely, CT (MALS001), CB (MALS002), and CD (MALS003) for their antimicrobial, cytotoxic, antiproliferative, genomic, and proteomic profiles. Although in vitro cytotoxic and antiproliferative potential were observed predominantly in CD MALS003, genome analysis revealed pathogenic potential of CB MALS002 and CT MALS001. Pangenome analysis revealed the presence of several accessory genes typically involved in fitness, virulence, and resistance characteristics in the core genomes of sequenced strains. The presence of an array of virulence and antimicrobial resistance genes in CB MALS002 and CT MALS001 suggests their potential role as emerging pathogens with significant impact on planetary health.
Al-KhaldiSF, MossobaMM, AllardMM, et al.Bacterial identification and subtyping using DNA microarray and DNA sequencing. Methods Mol Biol, 2012; 881:73–95; doi: 10.1007/978-1-61779-827-6_4
AzizRK, BartelsD, BestA, et al.The RAST Server: Rapid annotations using subsystems technology. BMC Genomics, 2008; 9:1–15; doi: 10.1186/1471-2164-9-75
5.
BartlettJG, GerdingDN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis, 2008; 46:12–18; doi: 10.1086/521863
6.
BidetP, BarbutF, LalandeV, et al.Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett, 1999; 175(2):261–266; doi: 10.1111/J.1574-6968.1999.tb13629.x
7.
BotteryMJ, PitchfordJW, FrimanVP. Ecology and evolution of antimicrobial resistance in bacterial communities. ISME J, 2020; 15(4):939–948; doi: 10.1038/s41396-020-00832-7
8.
BüchlerAC, RampiniSK, StellingS, et al.Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: An analysis done at the University Hospital of Zurich. BMC Infect Dis, 2014; 14(1):1–9; doi: 10.1186/S12879-014-0607-z
9.
CassirN, BenamarS, CroceO, et al.Clostridium species identification by 16S rRNA pyrosequencing metagenomics. Clin Infect Dis, 2016a;62(12):1616–1618; doi: 10.1093/cid/ciw203
10.
CassirN, BenamarS, La ScolaB. Clostridium butyricum: from beneficial to a new emerging pathogen. Clin Microbiol Infect, 2016b;22(1):37–45; doi: 10.1016/j.cmi.2015.10.014
11.
ChenKY, RathodJ, ChiuYC, et al.The transcriptional regulator Lrp contributes to toxin expression, sporulation, and swimming motility in Clostridium difficile. Front Cell Infect Microbiol, 2019; 9:356; doi: 10.3389/fcimb.2019.00356
12.
ChenL, ZhengD, LiuB, et al.VFDB 2016: Hierarchical and refined dataset for big data analysis—10 years on. Nucleic Acids Res, 2016; 44:694–697; doi: 10.1093/nar/gkv1239
13.
ChenS, GuH, SunC, et al.Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections. Infection, 2017; 45(3):255–262; doi: 10.1007/S15010-016-0940-9
DingleTC, MulveyGL, ArmstrongGD. Mutagenic analysis of the Clostridium difficile flagellar proteins, fliC and fliD, and their contribution to virulence in hamsters. Infect Immun, 2011; 79(10):4061; doi: 10.1128/iai.05305-11
18.
EdwardsAN, KarimST, PascualRA, et al.Chemical and stress resistances of Clostridium difficile spores and vegetative cells. Front Microbiol, 2016; 7:1698; doi: 10.3389/fmicb.2016.01698
19.
EnneVI, DelsolAA, RoeJM, et al.Evidence of antibiotic resistance gene silencing in Escherichia coli. Antimicrob Agents Chemother, 2006; 50(9):3003–3010; doi: 10.1128/aac.00137-06
FeldgardenM, BroverV, HaftDH, et al.Validating the AMRFINder tool and resistance gene database by using antimicrobial resistance genotype-phenotype correlations in a collection of isolates. Antimicrob Agents Chemother, 2019; 63(11):1–19; doi: 10.1128/aac.00483-19
22.
FerrarisL, ButelMJ, CampeottoF, et al.Clostridia in premature neonates' gut: Incidence, antibiotic susceptibility, and perinatal determinants influencing colonization. PLoS One, 2012; 7(1):e30594; doi: 10.1371/journal.pone.0030594
23.
GeierRR, RehbergerTG, SmithAH. Comparative genomics of Clostridium perfringens reveals patterns of host-associated phylogenetic clades and virulence factors. Front Microbiol, 2021; 12:1315; doi: 10.3389/fmicb.2021.649953
GreenMR, SambrookJ. Isolation of high-molecular-weight DNA using organic solvents. Cold Spring Harb Protoc, 2017; 2017(4):pdb.prot093450; doi: 10.1101/pdb.prot093450
26.
Huerta-CepasJ, ForslundK, CoelhoLP, et al.Fast genome-wide functional annotation through orthology assignment by eggNOG-mapper. Mol Biol Evol, 2017; 34(8):2115–2122; doi: 10.1093/molbev/msx148
27.
JinD, LuoY, HuangC, et al.Molecular epidemiology of Clostridium difficile infection in hospitalized patients in eastern China. J Clin Microbiol, 2017; 55(3):801–810; doi: 10.1128/jcm.01898-16
28.
KanaiT, MikamiY, HayashiA. A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease. J Gastroenterol, 2015; 50(9):928–939; doi: 10.1007/S00535-015-1084-x
29.
KourtisAP, WeinerR, BelsonK, et al.Clostridium tertium meningitis as the presenting sign of a meningocele in a twelve-year-old child. Pediatr Infect Dis J, 1997; 16(5):527–529; doi: 10.1097/00006454-199705000-00017
30.
Kowalska-KrochmalB, Dudek-WicherR. The minimum inhibitory concentration of antibiotics: Methods, interpretation, clinical relevance. Pathog, 2021; 10(2):165; doi: 10.3390/pathogens10020165
31.
KumarS, StecherG, LiM, et al.MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol, 2018; 35(6):1547–1549; doi: 10.1093/molbev/msy096
LewJF, WiedermannBL, SneedJ, et al.Aerotolerant Clostridium tertium brain abscess following a lawn dart injury. J Clin Microbiol, 1990; 28(9):2127–2129; doi: 10.1128/jcm.28.9.2127-2129.1990
35.
LimaBB, FonsecaBF, Amado N daG, et al.Clostridium difficile toxin A attenuates Wnt/β-catenin signaling in intestinal epithelial cells. Infect Immun, 2014; 82(7):2680–2687; doi: 10.1128/iai.00567-13
36.
LowLY, HarrisonPF, GouldJ, et al.Concurrent host-pathogen transcriptional responses in Clostridium perfringens murine myonecrosis infection. MBio, 2018; 9(2):e00473-18; doi: 10.1128/mbio.00473-18
37.
MahonC, ManuselisG.Textbook of Diagnostic Microbiology. W.B. Saunders Company: Tokyo; 1995.
38.
MelnykAH, WongA, KassenR. The fitness costs of antibiotic resistance mutations. Evol Appl, 2015; 8(3):273–283; doi: 10.1111/eva.12196
39.
MooreRJ, LaceyJA. Genomics of the pathogenic Clostridia. Microbiol Spectr, 2019; 7(3); doi: 10.1128/microbiolspec.gpp3-0033-2018
40.
MuñozM, Restrepo-MontoyaD, KumarN, et al.Comparative genomics identifies potential virulence factors in Clostridium tertium and C. paraputrificum. Virulence, 2019; 10(1):657–676; doi: 10.1080/21505594.2019.1637699
41.
Neumann-SchaalM, JahnD, Schmidt-HohagenK. Metabolism the difficile way: The key to the success of the pathogen Clostridioides difficile. Front Microbiol, 2019; 10:219; doi: 10.3389/fmicb.2019.00219
42.
PageAJ, CumminsCA, HuntM, et al.Roary: Rapid large-scale prokaryote pan genome analysis. Bioinformatics, 2015; 31(22):3691–3693; doi: 10.1093/bioinformatics/btv421
43.
PereiraFC, SaujetL, ToméAR, et al.The spore differentiation pathway in the enteric pathogen Clostridium difficile. PLoS Genet, 2013; 9(10):e1003782; doi: 10.1371/journal.pgen.1003782
44.
PrasadASB, ShrupthaP, PrabhuV, et al.Pseudomonas aeruginosa virulence proteins pseudolysin and protease IV impede cutaneous wound healing. Lab Investig, 2020; 100(12):1532–1550; doi: 10.1038/s41374-020-00478-1
45.
PrjibelskiA, AntipovD, MeleshkoD, et al.Using SPAdes De Novo Assembler. Curr Protoc Bioinforma, 2020; 70(1):1–29; doi: 10.1002/cpbi.102
46.
RanfordJC, HendersonB. Chaperonins in disease: mechanisms, models, and treatments. Mol Pathol, 2002; 55(4):209; doi: 10.1136/mp.55.4.209
47.
RiggsMM, SethiAK, ZabarskyTF, et al.Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis, 2007; 45(8):992–998; doi: 10.1086/521854
48.
RinehA, KelsoMJ, VatanseverF, et al.Clostridium difficile infection: Molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther, 2014; 12(1):131–150; doi: 10.1586/14787210.2014.866515
49.
RoehlHH, ConradSE. Identification of a G1-S-phase-regulated region in the human thymidine kinase gene promoter. Mol Cell Biol, 1990; 10(7):3834–3837; doi: 10.1128/mcb.10.7.3834-3837.1990
50.
SaxtonK, BainesSD, FreemanJ, et al.Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model. Antimicrob Agents Chemother, 2009; 53(2):412–420; doi: 10.1128/AAC.00306-08
51.
SchmidtR, CordovezV, De BoerW, et al.Volatile affairs in microbial interactions. ISME J, 2015; 9(11):2329–2335; doi: 10.1038/ismej.2015.42
SpigagliaP, MastrantonioP, BarbantiF. Antibiotic resistances of Clostridium difficile. Adv Exp Med Biol, 2018; 1050:137–159; doi: 10.1007/978-3-319-72799-8_9
58.
SteensmaEA, ErtlCW, BurkeLH. Clostridium tertium isolated from a necrotizing soft tissue infection in a diabetic but otherwise nonimmunocompromised patient. J Am Col Certif Wound Spec, 2011; 3(2):42; doi: 10.1016/j.jcws.2011.09.002
59.
StogiosPJ, SavchenkoA. Molecular mechanisms of vancomycin resistance. Protein Sci, 2020; 29(3):654–669; doi: 10.1002/pro.3819
60.
StothardP, WishartDS. Circular genome visualization and exploration using CGView. Bioinformatics, 2005; 21(4):537–539; doi: 10.1093/bioinformatics/bti054
61.
TarashiS, ZamaniMS, OmraniMD, et al.Commensal and pathogenic bacterial-derived extracellular vesicles in host-bacterial and interbacterial dialogues: Two sides of the same coin. J Immunol Res, 2022; 2022:8092170; doi: 10.1155/2022/8092170
UtturkarSM, KlingemanDM, Bruno-BarcenaJM, et al.Sequence data for Clostridium autoethanogenum using three generations of sequencing technologies. Sci Data, 2015; 2(1):1–9; doi: 10.1038/sdata.2015.14
64.
VerherstraetenS, GoossensE, ValgaerenB, et al.Perfringolysin O: The underrated Clostridium perfringens toxin?. Toxins (Basel), 2015; 7(5):1702–1721; doi: 10.3390/toxins7051702
65.
VuottoC, DonelliG, BuckleyA, et al.Clostridium difficile biofilm. Adv Exp Med Biol, 2018; 1050:97–115; doi: 10.1007/978-3-319-72799-8_7
66.
ZhangJ, SunJ, ChenX, et al.Combination of Clostridium butyricum and corn bran optimized intestinal microbial fermentation using a weaned pig model. Front Microbiol, 2018; 9:3091; doi: 10.3389/fmicb.2018.03091
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
